M&A in the Contract Manufacturing Industry: Implications and Outlook – 2024 Edition
Summary
This report is the fifth edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.
Scope
This 53-page report gives important, expert insight you won’t find in any other source. 12 tables and 19 figures throughout the report illustrate major points and trends. This report is required reading for -
- CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking
- Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence
- Private equity and stock analysts: target identification and analysis, portfolio company performance benchmarking
- Overview of M&A in the Pharma CMO Industry
- Detailed view of CDMO performance by number of deals, based on GlobalData's Deals database
- Analysis of M&A and private equity investment by target's specific manufacturing services
- Executive Summary
- Players
- Table Figure 1: Leading acquirers in the global pharma CMO industry, 2023
- Technology Briefing
- Deal types
- Trends
- Table Figure 2: Top M&A trends, 2023
- Table CMO M&A trends, 2023
- Industry Analysis
- Objectives and methodology
- Overview of M&A activity 2023
- Table Figure 3: CMO M&A activity, 2023
- Table Figure 4: CMO M&A activity by year, 2018-23
- Table Figure 5: CMO M&A activity percentage change by year, 2019-23
- Target characteristics
- Table Figure 6: Company acquisitions by target service offering, 2023
- Table Company acquisitions by target service offering and year, 2018-23
- Table Figure 7: Company acquisitions by target ownership, 2023
- Table Figure 8: Company acquisitions by target ownership and service type, 2023
- Table Company acquisitions by target service offering and target ownership, 2023
- Table Company acquisitions by target service offering and deal region, 2023
- Table Figure 9: Acquisition targets by sophistication of capabilities, 2023
- Acquirer characteristics
- Table Figure 10: Number of acquisitions, by acquirer's core business, 2023
- Table Figure 11: Number of acquisitions by acquirer's ownership, 2023
- Table Figure 12: Number of acquisitions by acquirer's ownership and target service type
- Table Company acquisitions by target service offering and acquirer ownership, 2023
- Geography
- Table Figure 13: Number of acquisitions by target country, 2023
- Top acquirers
- Table Figure 14: Most active acquirers, 2023
- Biosynth acquires Celares and Pepceuticals
- IPCA Laboratories invests in Unichem
- Target segment close-ups
- Multi
- API-small molecule
- API-biologic
- Commercial dose manufacturing
- Table Figure 15: Dose forms manufactured by acquired manufacturers (all service types), 2023
- Deal advisors
- Top financial advisors
- Table Figure 16: Top financial advisors to company acquisitions, 2023
- Top legal advisors
- Table Figure 17: Top legal advisors to company acquisitions, 2023
- Top financial advisors
- Valuations
- Table Services deals with known transaction value and multiples, 2023
- Facility acquisitions
- Table Figure 18: Pharma CMO facility acquisitions, 2023
- Table Facility acquisitions by CMOs, 2023
- What it means
- Drug shortages drive low-tech small molecule deals.
- Multi-service and injectable manufacturers targeted
- Catalent acquisition shakes up pharma and CMO landscape.
- Biologic acquisitions decreased in 2023 but strong interest remains, despite BIOSECURE Act complicating manufacturing agreements
- Private equity investments declined
- Table Private equity deals, 2023
- The outlook for M&A
- API - biologic targets
- Table Potential targets: API - biologic (protein & peptide) service providers
- API - cell and gene therapy targets
- Table Potential targets: API - biologic (gene and cell therapy) service providers
- API - biologic targets
- Value Chain
- Table Figure 19: The contract manufacturing value chain
- Companies
- Table Company acquisitions and private equity deals, 2023
- Appendix
- Methodology
- Bibliography
- Primary research - key opinion leaders
- Further reading
- Table Further reading
- About the Authors
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook